Human subjects
The proband was a patient observed in Department of Neurology, Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China. Peripheral venous blood from the patient and his family members was collected for genetic analyses. Primary fibroblasts were isolated from skin biopsy samples of the patient and an age-matched healthy volunteer. Informed consent was obtained from all subjects involved according to the Helsinki Declaration. The study was approved by the Ethics Committee of Shanghai Ninth People’s Hospital, School of Medicine, Shanghai Jiao Tong University.
Next-generation Sequencing Analysis And Sanger Sequencing
Genomic DNA was extracted using QIAamp DNA extraction kit (QIAGEN), and the concentration was measured. DNA was then fragmented by DNase and purified by magnetic bead method, followed by PCR amplification and ligation of the adapter sequences. Further, it was captured and purified twice by a custom Panel probe (Illumina Inc, USA), and then amplified by PCR. The final library obtained after purification was used to sequence exon regions of Panel-related genes on a NextSeq500 sequencer (Illumina Inc, USA). All data were compared to the reference sequence (UCSC hg19) using the BWA algorithm with the instrument’s default settings [16] and data reporting methods for annotation [17]. By implementing clinical data and the prediction results of bioinformatics software including PolyPhen2, LRT, Mutation Taster, the functional, mutation and genetic patterns of each gene were screened to obtain the list of candidate mutations. PCR primers were designed for the sites of candidate mutations in the patient’s parents for amplification and Sanger sequencing verification.
Primary Fibroblast Culture
Briefly, after local sterilization and anesthesia, full-thickness skin biopsies (∼ 5 mm3) were taken from the patient and a 25-year-old healthy volunteer. The isolates were placed into 50-ml conical tubes filled with biopsy culture medium containing 400 ml minimum essential medium, 100 ml fetal bovine serum, 5 ml penicillin/streptomycin solution (10,000 U/ml penicillin G and 10,000 µg/ml streptomycin) and stored in culture medium for 12 hours at 4 °C before dissection for primary culture. After removing the biopsy culture medium, the biopsy samples were washed three times with 10 ml DPBS without calcium and magnesium. Further, they were placed to a sterile 6-cm tissue culture dish containing ∼ 7 ml primary culture medium containing 400 ml minimum essential medium, 100 ml fetal bovine serum, 5 ml penicillin/streptomycin/Fungizone solution (10,000 U/ml penicillin G, 10,000 µg/ml streptomycin, 25 µg/ml amphotericin B) and anti-mycoplasma reagent. The biopsies were first cut into small pieces, then refined to pieces with the size of a pinhead. Further, we placed each 10 pinhead-sized explants into one 25-cm2 tissue culture–treated flask (Nunc™ EasYFlask™ 156340), waited for 20 minutes for the explants to adhere and added 12 ml primary culture medium. The flasks were placed into a dedicated 37 °C, 5% CO2 incubator for 5 days, followed by replacement of the medium by fresh primary culture medium. The fibroblast cultures were further maintained, checked daily for growth, confluence and contamination, with medium replacements every 3–5 days according to Villegas et al [18]. When the confluence was ~ 95%, the passage 2 fibroblasts from patient and healthy volunteer were seeded into two 96-well plates with the densities 3–9 × 103 cells/ml. Drug treatment was started when the confluence reached 60%~70%. Two drugs were used to target the mitochondria function of the fibroblasts. Butylphthalide sodium chloride (further referred to as butylphthalide, EnBiPu, CSPC NMP pharmaceutical company, H20100041) was diluted from the 25 mg/100 ml 0.9% sodium chloride stock solution in DMEM and used in final concentrations 10 µM and 26.28 µM. 70 mM idebenone stock solution was made by dissolving 30 mg tablets (Qilu Pharmaceutical Co., H10970137) in 0.2% DMSO, followed by dilution in DMEM to get a 5 µM final concentration. After addition of the drugs, the fibroblasts were incubated 48 hours in a 37 °C, 5% CO2 humidified incubator followed by immunofluorescent analysis. The cells were incubated for one hour with 1:20000 MitoTracker Orange (Molecular probes M7510) in a 37 °C, 5% CO2 humidified incubator). Further, we incubated with 1:20000 Hoechst 33342 (Invitrogen, #H3570) in 1 × PBS for 5 minutes at room temperature. Then the cells were fixed in 4% PFA (Aladdin, C104188) for 20 minutes, washed twice with 1 × PBS, permeabilized with 0.2% Triton X-100 for 15 minutes, blocked by 0.2% Triton X-100, 5% normal goat serum (Biotopped, SU3757) in PBS for 1 hour at room temperature. 1:1000 anti-LC3B primary antibody (Thermo Fisher, PA5-30598) diluted in 1 × PBS with 0.2% Triton X-100, 5% serum, was incubated overnight at 4 °C followed by washing and incubation for 1 hour at room temperature in 2 µg/ml of anti-rabbit IgG (H + L) highly cross absorbed secondary antibody conjugate with Alexa Fluor Plus 647 (Thermo A-21245), diluted in 1 × PBS with 0.2% Triton X-100. LC3B and MitoTracker signal was visualized under an Olympus IX73 microscope after immunocytochemistry staining. COOLLED PE300 were used as the illumination sources. Fluorescence emission was collected by 60 × objective, passed through EM 680/40 and EM 617/73 emission filters for LC3B and MitoTracker, respectively. All the images were acquired and processed by Micro-Manager software. The same conditions were applied to all samples. Fluorescence intensity was quantified by calculating the average cytoplasmic LC3B signal normalized to the number of cells by using MCID and Prism (GraphPad) software.
Statistical analysis
For the in vitro experiment’s analyses, we used ordinary two-way ANOVA followed by Holm-Sidak’s multiple comparisons test vs. each healthy individual’s fibroblasts in every treatment group and ordinary one-way ANOVA followed by Holm-Sidak’s multiple comparisons test at all treated patient groups vs. the untreated patient group. The levels of significance were set at *P < 0.05 and **P < 0.001. Values were presented as mean ± standard error of mean (SEM).